2nd Quarter - Report
DLA PIPER LLP (US) for PLASMA PROTEIN THERAPEUTICS ASSOCIATION
Firm
Income
$30,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Medicare reimbursement relating to plasma protein therapies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| NICOLE CARELLI | — |
| VANESSA L. CRAMER | — |
Health Issues HCR
Orphan exemption to the annual pharmaceutical fee; Orphan drug tax credit; Patient access to therapies; H.R. 2315/S. 1128, Preserving Access to Orphan Drugs Act; H.R. 460, Patients Access to Treatments Act; H.R. 3116, Modernizing Our Drug and Diagnostics Evaluation and Regulatory Network Cures Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| NICOLE CARELLI | — |
| VANESSA L. CRAMER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.